SMURF1 and prostate carcinoma: Li et al. discovered that DAB2IP is degraded by Smurf1 in a ubiquitination-dependent manner, hence the depletion of Smurf1 results in the upregulation of DAB2IP, thereby inhibiting the proliferation and migration of breast and prostate cancer cells (Li et al., 2016).